Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes
Article first published online: 28 JAN 2014
© 2014 Clinical Cytometry Society
Cytometry Part B: Clinical Cytometry
Volume 86, Issue 3, pages 207–215, May 2014
How to Cite
How to cite this article: Absence of Aberrant Myeloid Progenitors by Flow Cytometry is Associated with Favorable Response to Azacitidine in Higher Risk Myelodysplastic Syndromes. Cytometry Part B 2014;86B:207–215., , , , , , , , , .
- Issue published online: 9 APR 2014
- Article first published online: 28 JAN 2014
- Manuscript Accepted: 9 JAN 2014
- Manuscript Revised: 16 DEC 2013
- Manuscript Received: 4 AUG 2013
- Celgene Corporation (Gert J. Ossenkoppele and Arjan A. van de Loosdrecht)
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!